ResearchPhase II Trial of Vemurafenib and Sorafenib Combination in Advanced-Mutated Metastatic Pancreatic Cancer
ResearchA randomized phase II trial of gemcitabine, nab-paclitaxel, cisplatin with or without a medically supervised ketogenic diet for patients with metastatic pancreatic cancer
ResearchSkin microbiome differences in pancreatic adenocarcinoma, other cancers, and healthy controls: a pilot study
ResearchRetrospective analysis of capecitabine maintenance therapy in pancreatic ductal adenocarcinoma
ResearchAdult pancreatoblastoma: Systematic review of the literature and case report of a young adult patient
ResearchExosomal ALPPL2 and THBS2 as biomarkers for early detection and disease monitoring of pancreatic ductal adenocarcinoma
ResearchConfirmatory Clinical Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma
ResearchPhase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancer
ResearchCross-platform comparison of gene expression-based cancer molecular subtyping reveals discrepancies with exome capture methods
ResearchValidation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma
ResearchFirst-in-Human Phase I Study of Minnelide in Patients With Advanced Gastrointestinal Cancers: Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity
ResearchResults of a Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Trial of Nabpaclitaxel + Gemcitabine ± Olaratumab in Treatment-Naïve Participants with Metastatic Pancreatic Cancer
ResearchRelacorilant plus nab-paclitaxel for the treatment of metastatic pancreatic ductal adenocarcinoma: results from the open-label RELIANT study
ResearchHand therapy interventions for the prevention of chemotherapy-induced peripheral neuropathy of the hands in patients with pancreatic cancer